Melodiol Global Health (COPHF) Stock Price, News & Analysis

Company Overview

Melodiol Global Health Corp. is a Canada-based life sciences company engaged in the research, development and commercialization of cannabinoid- and plant-derived health products. The company’s primary focus lies in leveraging proprietary extraction and formulation technologies to create next-generation therapies targeting chronic pain, inflammatory conditions and metabolic disorders. Through its licensing and collaboration agreements, Melodiol advances both consumer wellness products and pharmaceutical-grade candidates derived from phytocannabinoids and related natural bioactives.

Melodiol’s product pipeline comprises a mix of over-the-counter nutraceuticals and prescription-ready assets. Its formulation platform is designed to improve bioavailability and deliver precise dosing of active ingredients, with programs addressing osteoarthritis, idiopathic pulmonary fibrosis and other inflammatory diseases. The company collaborates with academic institutions and contract research organizations to pursue preclinical and clinical validation, while also developing scalable manufacturing processes for both research and commercial supply.

Headquartered in Alberta, Canada, Melodiol Global Health operates state-of-the-art extraction and R&D facilities in North America and maintains strategic partnerships to support global distribution. The company draws on cross-disciplinary expertise in chemical engineering, pharmacology and regulatory affairs as it seeks to advance its product candidates through regulatory pathways. Melodiol’s business model emphasizes a dual-track approach—delivering consumer health supplements in regulated markets while progressing novel therapeutic assets toward clinical milestones.

Key Stats

• Today's Range: $0.12 to $0.12
• 50-Day Range: $0.12 to $0.12
• 52-Week Range: $0.00 to $9.47
• Volume: N/A
• Average Volume: 451 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

COPHF Stock Analysis - Frequently Asked Questions

How have COPHF shares performed this year?

Melodiol Global Health's stock was trading at $0.1170 at the start of the year. Since then, COPHF stock has increased by 0.0% and is now trading at $0.1170.

When did Melodiol Global Health's stock split?

Shares of Melodiol Global Health reverse split before market open on Wednesday, June 5th 2024.The 1-30 reverse split was announced on Wednesday, June 5th 2024. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, June 5th 2024. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

How do I buy shares of Melodiol Global Health?

Shares of COPHF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:COPHF
• CIK: N/A
• Web: www.cresopharma.com
• Phone: 61-8-9389-3180
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A